The advanced glycation end products market covers products from several categories such as skincare products, dietary supplements and medical devices among others. Advanced glycation end products (AGEs) refer to a heterogeneous group of compounds and free radicals that are formed irreversibly when reducing sugars react with amino groups in proteins, lipids, and nucleic acids. AGE formation is accelerated in conditions like diabetes and aging. AGE-defenses products aim to manage AGE levels and provide anti-aging effects.
The global advanced glycation end products market is estimated to be valued at US$ 3,469.95 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period of 2023 to 2030.
Key Takeaways
Key players operating in the advanced glycation end products market are Lonza Group Ltd., DSM, Foodchem International Corporation, BASF SE, Parchem fine & specialty chemicals.
Key opportunities in the market include rising popularity of nutraceutical and functional food products. Several vendors are focusing on launching dietary supplements containing AGE inhibitors or breakers to capitalize on the growing health consciousness among consumers.
The market is witnessing expansion in regions like North America, Asia Pacific and Europe. Increasing support from private and public organizations regarding R&D projects for treatment of age-related diseases will boost the global adoption.
Market Drivers
Growing geriatric population: The proportion of geriatric population (aged 65 years or above) worldwide has doubled since 1980 and is growing at an unprecedented rate. With age, the risk of developing chronic conditions that are linked to AGE accumulation increases considerably. This is a major factor driving the AGEs market.
Increasing awareness about anti-aging solutions: Rapid urbanization, changing lifestyles and rising health consciousness have augmented the demand for cosmeceutical and nutraceutical products offering anti-aging benefits. Several vendors are launching AGEs inhibiting skincare and dietary formulations to capitalize on this trend.
Market Restraints
High price of advanced treatment modalities: Drugs and medical devices used for inhibiting/breaking down AGEs are generally expensive owing to intense R&D involved. This prevents their widespread adoption, especially in price-sensitive developing nations.
Lack of clinical evidence: While research suggests association between AGEs and various age-related chronic diseases, there is a need for more clinical studies to prove causality. This translates to lower confidence among physicians to recommend AGE-targeting therapeutics.
Here is the response without mentioning market size, CAGR or conclusion:
Segment Analysis
The anti-aging sub segment dominates the Advanced Glycation End Products market during the forecast period. Anti-aging products help prevent skin aging by reducing wrinkles, fine lines, and age spots. Rising awareness about appearance and growing geriatric population are increasing demand for anti-aging products globally.
Global Analysis
North America is projected to be the fastest growing region in the Advanced Glycation End Products market during 2023-2030. The growth can be attributed to rising prevalence of diabetes and growing health concerns in countries like the US and Canada. Asia Pacific will emerge as the second largest market led by countries like China and India. Continuous economic development and increasing disposable incomes are prompting people to spend more on personal care in Asia Pacific countries. Europe will capture a significant market share owing to improved healthcare infrastructure and rising number of R&D activities related to anti-aging products.
